Ceribell │ AI-Powered Point-of-Care EEG

Ceribell, Inc. is a medical technology company based in Sunnyvale, California, founded in 2014. The company focuses on transforming the diagnosis and management of serious neurological conditions, particularly in acute care settings. Ceribell is known for its innovative Ceribell System, a point-of-care electroencephalography (EEG) platform that provides rapid and cost-effective brain monitoring, specifically designed for use in intensive care units and emergency rooms. The Ceribell System features disposable headbands with non-invasive electrodes, pocket-sized recorders for capturing EEG signals, and an AI-powered seizure detection algorithm called Clarity. This technology allows healthcare providers to set up EEG monitoring in about six minutes, significantly reducing the time needed for traditional EEG setups. The system also includes a cloud-based portal for real-time access to patient data, enhancing clinical decision-making. Ceribell aims to improve patient outcomes by enabling earlier diagnosis and treatment of seizures, including those that are difficult to detect. The company has received substantial funding and employs over 280 people, with a focus on serving hospitals and critical care units across the United States.

• Employees 350
• Founded 2014
• Annual Revenue $71540000
• Total Funding $333000000